Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-1H vs ATG induction in solid organ transplantation with tacrolimus/MMF/steroids
2007-001815-51Phase 4Completed
- Sponsor
- University Hospital Vienna
- Start
- Dec 2007
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alemtuzumab, antithymocyte globulin, tacrolimus and mycophenolate mofetil in graft rejection (2 arms), sponsored by University Hospital Vienna. Started Dec 2007; status: completed.
02
Drugs
alemtuzumabantithymocyte globulintacrolimusmycophenolate mofetil
03
Conditions
graft rejection
Beyond the preview
Go deeper on 2007-001815-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001815-51.